MolecuLight Unveils Innovations in Wound Care at SAWC Fall 2025
MolecuLight Unveils Innovations in Wound Care at SAWC Fall 2025
The wound care industry is on the brink of a revolutionary shift with MolecuLight Corp., a leader in point-of-care fluorescence imaging, making significant contributions at the Symposium on Advanced Wound Care (SAWC) Fall 2025. Taking place from September 3 to 6 in Las Vegas, Nevada, this premier event gathers top clinicians and researchers to explore advancements in patient care. MolecuLight's presence at the conference promises to set new standards in wound management.
At booth #327, attendees will get a firsthand look at the MolecuLightDX®+ device, which integrates several crucial imaging technologies into a single, fully handheld system. This device is designed for detecting bacterial presence, accurate wound measurement, and providing thermal imaging, all in one compact solution. Most notably, MolecuLight is set to introduce oxygenation imaging features within the MolecuLightDX®+, a capability expected to enhance clinicians' ability to assess wound healing viability effectively. The FDA submission for this feature is anticipated in Q4 2025, further demonstrating MolecuLight's commitment to advancing clinical capabilities in wound care.
MolecuLight's contributions to SAWC Fall include 10 scientific poster presentations that emphasize the real-world applications of their multimodal imaging platform. These posters cover various topics, such as:
- - Patient Engagement and Education: Focusing on enhancing communication and decision-making through advanced imaging techniques.
- - Intraoperative and Preoperative Use: Supporting surgical teams with real-time insights into wound conditions to improve patient outcomes.
- - Wound Hygiene and Debridement: Providing tools for more effective cleaning practices by identifying bacterial hotspots within the wound.
- - Thermal Imaging in Wound Care: Discussing the significance of temperature mapping for objective wound assessments.
MolecuLight’s advancement is not just limited to the addition of oxygenation imaging. The MolecuLightDX®+ is designed to integrate seamlessly with Electronic Health Records (EHR) platforms like Epic, making it easier for clinicians to document patient data and streamline workflows. This is crucial in today’s fast-paced healthcare environment, as the pressure for efficiency and precision continues to rise.
The security and reliability of this imaging technology are ensured by its compliance with HIPAA and its SOC 2 certification, backed by extensive clinical evidence including over 100 peer-reviewed publications. This means that healthcare professionals can confidently utilize MolecuLight imaging for any wound, regardless of the clinical setting. Furthermore, MolecuLight is looking forward to receiving MDDT (Medical Device Development Tool) FDA qualification for their wound measurement technology, validating its precision and consistency in clinical environments.
Anil Amlani, CEO of MolecuLight, states, "SAWC Fall is a leading forum for advancing wound care, and we're proud to contribute 10 scientific posters that showcase the broad clinical value of MolecuLight's technology. Our platform is transforming wound assessment and documentation, ultimately leading to improved patient outcomes. We are excited about the upcoming addition of oxygenation imaging and the anticipated FDA clearance of our wound measurement technology. This development will position the MolecuLightDX®+ as an all-in-one solution for clinicians and researchers alike."
Visitors to SAWC Fall are encouraged to stop by MolecuLight’s booth for live demonstrations of the MolecuLightDX®+ device and to learn how its innovative technology is set to transform wound assessment, patient outcomes, and clinical workflows.
As the wound care landscape continues to evolve, MolecuLight stands at the forefront, fueled by a commitment to innovation and excellence in patient care. The implications for enhanced healing practices across healthcare settings are profound, ensuring this technology's crucial role in shaping the future of wound management.
For more information on MolecuLight and the MolecuLightDX®+, be sure to attend SAWC Fall 2025 and explore how these advancements can benefit clinical practices and patient care.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.